SEC Form 4 · accession 0000891293-15-000015

CTI BIOPHARMA CORP · CTIC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, Corporate Development

Period of report

Apr 6, 2015

Accepted (ET)

Apr 8, 2015 · 5:43 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000891293

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 6, 2015	S	800	$1.86	D	727,509	D
Common Stock	Apr 6, 2015	S	800	$1.865	D	726,709	D
Common Stock	Apr 6, 2015	S	5,300	$1.87	D	721,409	D
Common Stock	Apr 6, 2015	S	769	$1.875	D	720,640	D
Common Stock	Apr 6, 2015	S	1,900	$1.88	D	718,740	D
Common Stock	Apr 6, 2015	S	2,000	$1.885	D	716,740	D
Common Stock	Apr 6, 2015	S	1,400	$1.89	D	715,340	D
Common Stock	Apr 6, 2015	S	100	$1.895	D	715,240	D
Common Stock	Apr 6, 2015	S	1,600	$1.90	D	713,640	D
Common Stock	Apr 6, 2015	S	100	$1.905	D	713,540	D
Common Stock	Apr 6, 2015	S	1,400	$1.91	D	712,140	D
Common Stock	Apr 6, 2015	S	100	$1.915	D	712,040	D
Common Stock	Apr 6, 2015	S	300	$1.92	D	711,740	D

No Table II lines on this filing.